AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04080466 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Blood/Urine Collection
Description: Collection of blood and urine allows the researchers to look for a biomarker in the blood and urine that might help to predict the evolution of disease/hip osteoarthritis. Identifying a marker in the blood and urine that could be used for early detection of individuals with cam deformity that are at-risk of hip degeneration could greatly improve patient care.~Participants in the Cam Group will undergo the blood and urine collection twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo a blood and urine collection once as part of the study.
Study NCT04080466 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient Reported Questionnaires
Description: The purpose of the questionnaires is to assess how much trouble the participant is having with their hip and how it affects their quality of life.~Participants in the Cam Group will complete the questionnaires twice; once before surgery and once 2-years post-operative. Participants in the Control Group will complete the questionnaires once as part of the study.
Study NCT04080466 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Reported Questionnaires
Description: The purpose of the questionnaires is to assess how much trouble the participant is having with their hip and how it affects their quality of life.~Participants in the Cam Group will complete the questionnaires twice; once before surgery and once 2-years post-operative. Participants in the Control Group will complete the questionnaires once as part of the study.
Study NCT04080466 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: EOS Scan
Description: The EOS® uses a new imaging technique that allows precise measurement of the hip and pelvis geometry and structure. This innovative x-ray technique exposes participants to 2-10 times less radiation than a routine x-ray and can capture multiple images at once.~Participants in the Cam Group will undergo the EOS scan twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo the scan once as part of the study.
Study NCT04080466 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: EOS Scan
Description: The EOS® uses a new imaging technique that allows precise measurement of the hip and pelvis geometry and structure. This innovative x-ray technique exposes participants to 2-10 times less radiation than a routine x-ray and can capture multiple images at once.~Participants in the Cam Group will undergo the EOS scan twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo the scan once as part of the study.
Study NCT04080466 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: PET-MRI
Description: Positron emission tomography combined with magnetic resonance imaging (PET-MRI) is a technology that allows physicians to examine bone and cartilage at the molecular level.~Participants in the Cam Group will undergo the scan twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo the scan once as part of the study.
Study NCT06525090 — intervention group
Intervention type: OTHER
Intervention: no intervention-child-administered questionnaires
Description: The implementation of the research was started after getting approval from Mugla Sıtkı Kocman University Health Sciences Ethics Committee and TR Ministry of National Education Research, Competition and Social Activity. The purpose of the study was explained by the researchers to the administrators of the schools where the study was conducted and planning was made with the school administration. The data were collected in 15-20 minutes from the students who agreed to participate in the study during the course hours deemed appropriate by the administration. The purpose of the study and how to fill in the measurement tools was explained to the students, and it was stated that the research data would be kept confidential and used only by the researcher. The self-administered questionnaires were filled out on the paper. Verbal consent was obtained from the students participating in the study and written informed consent was obtained from their parents.
Study NCT06525584 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hcl 50Mg/Ml Inj
Description: ketamine infusion at a dose of 0.1 mg/kg/hour for 16 hours
Study NCT06525584 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hcl 50Mg/Ml Inj
Description: ketamine infusion at a dose of 0.3 mg/kg/hour for 16 hours
Study NCT06525584 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Without ketamine
Study NCT06294340 — intervention group
Intervention type: OTHER
Intervention: Exposure to loud pre-recorded road traffic noise
Description: Participants of both arms will be exposed to the same loud pre-recorded road traffic noise in a laboratory setting.
Study NCT05894551 — intervention group
Intervention type: OTHER
Intervention: Evaluation of q angles different positions
Description: Q angle evaluation in two different static postures (upright and supine position) and dynamic posture during the midstance phase of the gait
Study NCT05894551 — intervention group
Intervention type: OTHER
Intervention: Physical examination
Description: With goniometric evaluations, the femoral anteversion angle will be measured. Pelvis width and thigh length will be measured with a tape measure. Quadriceps muscle strength, hamstring muscle strength, Hip abduction, adduction, internal and external rotation and extension muscle strength will be measured with hand-held dynamometer.~Joint mobility will be assessed with the Beighton score and foot posture will be evaluated with the foot posture index-6 (FPI-6).
Study NCT04506606 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Afferent block
Description: Block sensory feedback to evaluate hemodynamic and fatigue consequence of group III/IV muscle afferents
Study NCT05894551 — intervention group
Intervention type: OTHER
Intervention: Functional mobility assessment
Description: 10-meter walking test will be conducted to understand functional mobility.
Study NCT04951882 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: human derived umbilical cord derived mesenchymal stem cells
Description: intravenous transplantation of human derived umbilical cord derived mesenchymal stem cells
Study NCT05457712 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: protocol
Description: The energy and protein value of the prescribed diet will be followed according to the original protocol considering plans A, B or C, via a hypercaloric formula with a caloric density of 1kcal/ml for infants starting 60 days preoperatively. The return for nutritional monitoring will take place after evaluation: weekly, biweekly or monthly.
Study NCT05457712 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Afterwards, they will be evaluated through the standard nutritional protocol of the nutrition clinic of the Instituto de Cardiologia de and Hospital Santo Antonio de Porto Alegre, whose standard nutritional prescription is a polymeric formula with a caloric density of 0.67 kcal/ml. Nutritional monitoring will take place through telephone contact for information on the baby's clinical data and in person before the surgery is performed.
Study NCT06107361 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: B. Braun 6.35cm 20 gauge ultralong intravenous catheter
Description: B Braun Medical Inc, 6.35cm 20 gauge ultralong intravenous catheter
Study NCT06107361 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BD 5.71 cm 20 gauge Accucath
Description: Bard Access Systems, Inc, BD 5.71 cm 20 gauge ultralong intravenous catheter with guide wire
Study NCT04080466 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: PET-MRI
Description: Positron emission tomography combined with magnetic resonance imaging (PET-MRI) is a technology that allows physicians to examine bone and cartilage at the molecular level.~Participants in the Cam Group will undergo the scan twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo the scan once as part of the study.
Study NCT04080466 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motion Analysis
Description: Motion analysis is the study of how joints move and which muscles fire during specific movements. In the lab, participants will be asked to perform movements that they might do during a typical day or when exercising.~Participants in the Cam Group will undergo the Motion Analysis session twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo the Motion Analysis session once as part of the study.
Study NCT04080466 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Motion Analysis
Description: Motion analysis is the study of how joints move and which muscles fire during specific movements. In the lab, participants will be asked to perform movements that they might do during a typical day or when exercising.~Participants in the Cam Group will undergo the Motion Analysis session twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo the Motion Analysis session once as part of the study.
Study NCT04080466 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3T MRI
Description: Participants will undergo a 3-Tesla (3T) Magnetic Resonance Imaging (MRI) of both hips.~Participants in the Cam Group will undergo this scan once as part of their standard of care. Participants in the Control Group will undergo this scan once as part of the study.
Study NCT04080466 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: 3T MRI
Description: Participants will undergo a 3-Tesla (3T) Magnetic Resonance Imaging (MRI) of both hips.~Participants in the Cam Group will undergo this scan once as part of their standard of care. Participants in the Control Group will undergo this scan once as part of the study.
Study NCT06345807 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individuals activity programs
Description: activity program will be adjusted every week by practitioner for each patient following data coming from the wearable device ( connected whatch and bellt for 12 months)
Study NCT06345807 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: activity program
Description: pre established program without adjustement. The patient has connected whatch and bellt for 12 months
Study NCT06345807 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: no Physical Activity program
Description: no Physical Activity (PA)program but just PA recommendations.PA is carried out independently (common practice).The patient has connected whatch and bellt for 12 months
Study NCT05637086 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phenytoin
Description: Phenytoin remains a highly effective anti-epileptic drug, especially in generalized seizure management. Unfortunately, phenytoin efficacy on epileptic seizure is apparently reduced with its chronic use
Study NCT05637086 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenytoin
Description: Phenytoin remains a highly effective anti-epileptic drug, especially in generalized seizure management. Unfortunately, phenytoin efficacy on epileptic seizure is apparently reduced with its chronic use
Study NCT04906798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-385
Description: Test Drug
Study NCT04906798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D744
Description: Reference Drug
Study NCT05637086 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pentoxifylline 400 MG
Description: Pentoxifylline (PTX) has a well validated immune modulatory and anti-inflammatory efficacy
Study NCT05637086 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Celecoxib 200mg
Description: Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and help relieve symptoms of arthritis
Study NCT05453552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Granulocyte Colony-Stimulating Factor(G-CSF)
Description: G-CSF was administered at 5 ug/kg/day on days-17 to -10. When white blood cell is more than 20G/L, stop using G-CSF.
Study NCT05453552 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Granulocyte Colony-Stimulating Factor(G-CSF)
Description: G-CSF was administered at 5 ug/kg/day on days-17 to -10. When white blood cell is more than 20G/L, stop using G-CSF.
Study NCT05453552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine (DAC)
Description: Decitabine was administered at 20mg/m2/day on days -14 to -10.
Study NCT05453552 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Decitabine (DAC)
Description: Decitabine was administered at 20mg/m2/day on days -14 to -10.
Study NCT05453552 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Busulfan
Description: Busulfan was administered at 3.2 mg/kg/day on days -7 to -4 in G-CSF+DAC+BUCY group.
Study NCT05453552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine (FLU)
Description: Fludarabine was administered at 30 mg/m2/day on days -7 to -3.
Study NCT05453552 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide (CY)
Description: Cyclophosphamide was administered at 60 mg/kg/day on days -3,-2.
Study NCT05453552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan (BU)
Description: Busulfan was administered at 3.2 mg/kg/day on days -6 to -3 in G-CSF+DAC +BF group.
Study NCT04810715 — intervention group
Intervention type: OTHER
Intervention: Patients with Ankylosing Spondylitis
Description: Observational study, not applicable
Study NCT05013008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Finerenone (Kerendia, BAY94-8862)
Description: Oral tablet; starting at 10 mg or 20 mg; once daily; received in previous interventional Phase 3 trial FIGARO-DKD; no new intervention was administered in this biomarker study.
Study NCT05013008 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablet; starting at 10 mg or 20 mg; once daily; received in previous interventional Phase 3 trial FIGARO-DKD; no new intervention was administered in this biomarker study.
Study NCT06350175 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine Replacement Therapy Agent
Description: The NRT Agents-- 21mg nicotine patches (x14) and 2 mg nicotine lozenges (\~210).
Study NCT06350175 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: West Virginia Quit Line
Description: Instructional Pamphlets and contact information for the WV QL. A telehealth line set up to assist people of WV to quit smoking.
Study NCT06350175 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: West Virginia Quit Line
Description: Instructional Pamphlets and contact information for the WV QL. A telehealth line set up to assist people of WV to quit smoking.
Study NCT04670874 — intervention group
Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Complete quality of life questionnaire
Study NCT04670874 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete quality of life questionnaire
Study NCT05759663 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MIRRAD
Description: Repair of the diastasis with MIRRAD technique
Study NCT05759663 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Plication of the entire diastasis arm
Description: Plication of the entire diastasis
Study NCT05023239 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: UG-SZM Group
Description: The patients will be receive Ultrasound-Guided Suprazygomatic Maxillary Nerve Blocks 10 mL of a local anesthetic mixture composed of 0.25% plain bupivacaine .
Study NCT05023239 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: UG-SZM Group
Description: The patients will be receive Ultrasound-Guided Suprazygomatic Maxillary Nerve Blocks 10 mL of a local anesthetic mixture composed of 0.25% plain bupivacaine .
Study NCT06346639 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 16-day hot and cold acclimation
Description: Acclimation program will consist of 8 brief cold water immersions (CWI; 14°C 5 min) and 8 hot water immersions (HWI; 45°C 5 min). Heat and cold sessions will be performed on separate days (i.e., 1st day hot exposure, 2nd day cold exposure, 3rd day hot exposure, etc.).
Study NCT06600997 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flow Diversion for Endovascular Treatment of Intracranial Aneurysms
Description: Flow Diversion for Endovascular Treatment of Intracranial Aneurysms
Study NCT06600997 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional endovascular therapy (stent-assisted coiling, balloon-assisted coiling, or coiling) for endovascular treatment of intracranial aneurysms
Description: Conventional endovascular therapy (stent-assisted coiling, balloon-assisted coiling, or coiling) for endovascular treatment of intracranial aneurysms
Study NCT06606197 — intervention group
Intervention type: OTHER
Intervention: Having sex with other men
Description: Having sex with other men
Study NCT06606171 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Chair Sitting (30 minutes)
Description: This intervention involves a single session of chair sitting for 30 minutes, where participants will sit in a standardized non-swivel chair and perform desk-based activities like computer use.
Study NCT06606171 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floor Sitting (30 minutes)
Description: This intervention entails a single session of floor sitting for 30 minutes, with participants seated on a cushioned mat performing similar desk activities as in the chair sitting session.
Study NCT06606171 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daily Floor Sitting Practice (1 month)
Description: Participants will be instructed to incorporate at least one hour of floor sitting into their daily routine for a duration of one month.
Study NCT06601478 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The MedLIFE app
Description: The intervention arm will receive the lifestyle counselling by the MEDLIFE app, and the control arm will go on with standard lifestyle recommendations in the form of a two-page written handout.
Study NCT05330728 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suggestions for lifestyle changes+ Abdominal massage
Description: Suggestions for lifestyle changes+ abdominal massage will be applied. Suggestions including regular and balanced diet, fluid consumption, regular walking and abdominal exercises and correct toilet habits will be given once. Abdominal massage will be applied 3 times a week for 4 weeks.
Study NCT05330728 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Suggestions for lifestyle changes+ Kinesio taping
Description: Suggestions including regular and balanced diet, fluid consumption, regular walking and abdominal exercises and correct toilet habits will be given once. Kinesio taping will be applied 3 times a week for 4 weeks.
Study NCT05330728 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Suggestions for lifestyle changes
Description: Suggestions including regular and balanced diet, fluid consumption, regular walking and abdominal exercises and correct toilet habits will be given once.
Study NCT04853069 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Transdermal estradiol gel
Description: Patients will receive standard care +/- (randomsed 1:1) transdermal 17ß-estradiol gel (3 mg; applied to forearm, upper arm and shoulder) for ten days.
Study NCT06210828 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: Two weekly exercise sessions over a 12-week period at home via LINE Video call with physical therapist. Focusing on lower extremity strengthening and balance exercises. In addition to the guided sessions, participants are encouraged to perform self-directed exercises one day per week.
Study NCT06210828 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Receive fall prevention exercise brochure
Study NCT05365438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omega 3-Atorvastatin
Description: Atmeg 2 capsules with 1 pack of Omethyl cutielet
Study NCT05365438 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omega 3-Atorvastatin
Description: Atmeg 2 capsules
Study NCT05365438 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin-Ezetimibe
Description: ezetimibe/atorvastatin 10/20 mg
Study NCT04633096 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: tailored feedback of depression screening results
Description: The feedback for the participant contains the screening result, information about depression in general, guideline based treatment recommendations for patients and contact-information for treatment. The information is tailored to the participant's individual symptom profile, illness perceptions and preferences.
Study NCT04633096 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: standardized feedback of depression screening results
Description: The feedback for the participant contains the screening result, information about depression in general, guideline based treatment recommendations for patients and contact-information for treatment.